Merck Licenses Bone Drug for Generic Sale
50296
Merck & Company said it had signed a deal for an authorized generic form of its blockbuster osteoporosis drug Fosamax to become available in February.
745892
Sanofi-Aventis said on Friday that  U.S. regulators had approved wider use for its colon cancer  drug Eloxatin, lifting shares in the world's third-largest  pharmaceuticals group.
218831
FRANKFURT/ZURICH  - German drugmaker Merck KGaA   MRCG.DE unveiled a surprise $13.3 billion deal to buy   Europe's biggest biotech firm Serono SEO.VX on Thursday,   creating a new force in European pharmaceuticals.
285557
Unichem Laboratories has has entered into an agreement with Lannett Company of USA for the exclusive supply of one or more generic drug products.
196912
Nonbinding offers for the generics  business of Merck KGaA , worth at least 4 billion  euros ($5.3 billion), are due on Monday, a source close to the  sale process told Reuters, confirming a newspaper report.
480970
Swiss biotech company Addex Pharmaceuticals SA  said it could receive more than $700 million from Merck & Co Inc  for a licensing deal on its ADX63365 drug to treat schizophrenia, lifting its shares.
254545
An Indian drug maker, Ranbaxy Laboratories, said it had submitted a bid for the generics unit of the German drug maker Merck but did not disclose how much it was offering. Analysts say Merckâs generics unit could be worth as much as 5 billion euros ($6.6 billion). Merck said last month that it had started contacting companies that might be interested in acquiring its generics drugs unit. Two companies, Ranbaxy and the Actavis Group of Iceland, have publicly expressed an interest. Merck is based in Darmstadt.
214179
WASHINGTON -- Some influential members of Congress are renewing their pledge to help speed generic versions of the world's most expensive drugs to market.
271543
The Food and Drug Administration strongly endorsed Biogen Idec Inc.'s new multiple sclerosis treatment, putting the Cambridge firm in position to expand the market for MS drugs and win greater market share. The drug, formerly called Antegren but renamed Tysabri, was developed with Elan Pharmaceuticals of Ireland. The FDA approved Tysabri for use on its own and in ...
733825
Nonbinding offers for the generics business of Merck KGaA , worth at least 4 billion euros ($5.3 billion), are due on Monday, a source close to the sale process told Reuters, confirming a newspaper report.
44172
Biotech giant Inc. Amgen and the pharmaceuticals division of health-care products company Wyeth said Tuesday the Food and Drug Administration approved their arthritis treatment Enbrel to induce a major clinical
269171
Merck of Germany announced it would take control of Serono, a Swiss pharmaceutical maker, for 10.6 billion euros ($13.5 billion).
387468
Barr Pharmaceuticals Inc. BRL.N on  Friday said U.S. regulators had granted tentative approval to  the company's quickly-dissolving generic form of  GlaxoSmithKline Plc's GSK.L Zofran antinausea tablet.
722689
BETHESDA, Md.  - Drug maker Merck & Co. Inc.   urged U.S. advisers on Thursday to approve the first  over-the-counter sales of a cholesterol-lowering pill, but  regulators questioned if consumers would use it properly.
502454
The deal, which must be approved by regulators, will make the German group the number one generics company in Scandinavia, a growing market worth about 600m last year, according to Merck.
597708
Drug giant Merck says the Food and Drug Administration wants more information, but is prepared to approve the company&#39;s successor drug to recalled pain reliever Vioxx.
119762
The biotechnology company said Thursday that its experimental osteoporosis drug proved superior to Fosamax from Merck in a clinical trial.